BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21471440)

  • 1. Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8.
    Dang M; Rockell J; Wagner R; Wenzlau JM; Yu L; Hutton JC; Gottlieb PA; Davidson HW
    J Immunol; 2011 May; 186(10):6056-63. PubMed ID: 21471440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.
    Énée É; Kratzer R; Arnoux JB; Barilleau E; Hamel Y; Marchi C; Beltrand J; Michaud B; Chatenoud L; Robert JJ; van Endert P
    Diabetes; 2012 Jul; 61(7):1779-84. PubMed ID: 22586580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes.
    Xu X; Gu Y; Bian L; Shi Y; Cai Y; Chen Y; Chen H; Qian L; Wu X; Xu K; Mallone R; Davidson HW; Yu L; She J; Zhang M; Yang T
    Vaccine; 2016 Feb; 34(6):854-62. PubMed ID: 26541133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kobayashi M; Kuwahara H; Abiru N; Yamasaki H; Matsuura N; Miura J; Uchigata Y; Eguchi K
    Clin Immunol; 2011 Feb; 138(2):146-53. PubMed ID: 21067978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.
    Scotto M; Afonso G; Larger E; Raverdy C; Lemonnier FA; Carel JC; Dubois-Laforgue D; Baz B; Levy D; Gautier JF; Launay O; Bruno G; Boitard C; Sechi LA; Hutton JC; Davidson HW; Mallone R
    Diabetologia; 2012 Jul; 55(7):2026-31. PubMed ID: 22526607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
    Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
    Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
    Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
    Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
    Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
    Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
    J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes.
    Andersen ML; Vaziri-Sani F; Delli A; Pörksen S; Jacobssen E; Thomsen J; Svensson J; Steen Petersen J; Hansen L; Lernmark A; Mortensen HB; Nielsen LB
    Pediatr Diabetes; 2012 Sep; 13(6):454-62. PubMed ID: 22686132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
    Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
    Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4.
    Worsaae A; Hejnaes K; Moody A; Ludvigsson J; Pociot F; Lorenzen T; Dyrberg T
    Autoimmunity; 1995; 22(3):183-9. PubMed ID: 8734572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children.
    Paun A; Yau C; Meshkibaf S; Daigneault MC; Marandi L; Mortin-Toth S; Bar-Or A; Allen-Vercoe E; Poussier P; Danska JS
    Sci Immunol; 2019 Feb; 4(32):. PubMed ID: 30709843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes.
    Kawasaki E; Uga M; Nakamura K; Kuriya G; Satoh T; Fujishima K; Ozaki M; Abiru N; Yamasaki H; Wenzlau JM; Davidson HW; Hutton JC; Eguchi K
    Diabetologia; 2008 Dec; 51(12):2299-302. PubMed ID: 18850084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a luciferase-based system for the detection of ZnT8 autoantibodies.
    Ustinova J; Zusinaite E; Utt M; Metsküla K; Reimand K; Huchaiah V; Merits A; Uibo R
    J Immunol Methods; 2014 Mar; 405():67-73. PubMed ID: 24462542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.
    Petruzelkova L; Ananieva-Jordanova R; Vcelakova J; Vesely Z; Stechova K; Lebl J; Dusatkova P; Sumnik Z; Coles R; Powell M; Furmaniak J; Rees Smith B; Kolouskova S
    Diabet Med; 2014 Feb; 31(2):165-71. PubMed ID: 23952619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.
    Wenzlau JM; Liu Y; Yu L; Moua O; Fowler KT; Rangasamy S; Walters J; Eisenbarth GS; Davidson HW; Hutton JC
    Diabetes; 2008 Oct; 57(10):2693-7. PubMed ID: 18591387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.